Expression of survivin and p53 protein in pulmonary tumours Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
Immunohistocemical expression of P53 and BCL-2 in pateints with lung cancer: correlation with survival time Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006
Immunohistochemical expression of Bcl-2 and p53 in patients with lung cancer: Correlation with survival time Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
c-erbB-1 and c-erbB-2 receptors genetic abnormalities and protein expression in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 705s Year: 2004
ETS-1 mRNA and its association with T-BET and Th1 cytokine expression in active pulmonary sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018
Functional polymorphism of p53 and CCR5 genes in lung carcinoma and bronchail asthma Source: Eur Respir J 2005; 26: Suppl. 49, 591s Year: 2005
Polymorphism of chemokine receptor gene CCR5 in patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 266s Year: 2003
Chemokine mRNA expression profiling in pulmonary sarcoidosis Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008
Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008
The effect of adhesion molecule CEACAM1 and chemokine receptor CXCR4 expression on prognosis of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Decreased expression of VEGFR-2 mRNA in pulmonary vessels of COPD patients Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009
A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease Source: Eur Respir J 2012; 39: 1415-1424 Year: 2012
Combined expression of p53, Bcl-2 and p21WAF-1 proteins in endobronchial biopsies may be associated with lung cancer prognosis Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001
Contribution of genetic polymorphism of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, to the susceptibility and severity of non-small cell lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Chemokines and chemokine receptors mRNA expression in whole blood of COPD patients Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010
C-C chemokine receptor 2 gene polymorphism V64I and CCR2 expression on T lymphocytes in pulmonary sarcoidosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005
Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis is not associated with difference in expression of fas or fas ligand Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
E-cadherin and beta-catenin expression in imprints of NSCLC. Relationship with prognostic parameters Source: Eur Respir J 2006; 28: Suppl. 50, 769s Year: 2006
Proteinase-activated receptor-2 (PAR2 ) activation on human lung fibroblasts increases IL-6 & IL-8 mRNA expression Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside Year: 2003